MedTrace Logo

Brief Treatment for Posttraumatic Stress Disorder

NCT03033602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 169

Last updated 2023-05-24

Study results available
· View outcomes & findings →

Summary

The primary goal of this study is to examine whether a brief treatment approach for PTSD is equally efficacious in the treatment of active duty service members relative to a first line treatment approach that requires much greater treatment dose.

Conditions

Interventions

BEHAVIORAL

written exposure therapy

five sessions of writing about traumatic experience.

BEHAVIORAL

CPT, cognitive only

12 sessions of cognitive therapy related to traumatic experience.

Sponsors & Collaborators

  • University of Texas

    collaborator OTHER

  • United States Department of Defense

    collaborator FED

  • Boston VA Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Denise Sloan, Ph.D. · Boston VA Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-20
Primary Completion
2020-12-15
Completion
2021-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03033602 on ClinicalTrials.gov